Jefferies raises Varex Imaging stock price target to $12 on improving business conditions

Investing.comFriday, October 3, 2025 at 9:44:58 AM
Jefferies raises Varex Imaging stock price target to $12 on improving business conditions
Jefferies has raised its price target for Varex Imaging's stock to $12, reflecting improved business conditions for the company. This adjustment signals confidence in Varex's future performance and could attract more investors, highlighting the positive outlook for the imaging industry.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Jefferies raises Pinnacle West Capital stock price target to $113 on growth
PositiveFinancial Markets
Jefferies has raised its price target for Pinnacle West Capital's stock to $113, reflecting confidence in the company's growth potential. This adjustment is significant as it indicates a positive outlook for investors, suggesting that Pinnacle West is well-positioned to capitalize on future opportunities in the energy sector.
Jefferies reiterates Buy rating on Trip.com stock, maintains $85 price target
PositiveFinancial Markets
Jefferies has reaffirmed its Buy rating on Trip.com stock, setting a price target of $85. This endorsement reflects confidence in Trip.com's growth potential and market position, which is significant for investors looking for promising opportunities in the travel sector. With the ongoing recovery in travel demand, this positive outlook could attract more investors to the stock.
Occidental Petroleum stock holds steady as Jefferies maintains $44 target
NeutralFinancial Markets
Occidental Petroleum's stock price remains stable as Jefferies maintains its target price at $44. This consistency in stock valuation is significant for investors, indicating confidence in the company's performance despite market fluctuations. It suggests that Jefferies sees potential for growth or stability in Occidental's operations, which could influence investor decisions moving forward.
Victoria’s Secret price target raised to $35 from $30 at Jefferies on Fashion Show catalyst
PositiveFinancial Markets
Jefferies has raised its price target for Victoria's Secret from $30 to $35, citing the upcoming Fashion Show as a key catalyst for growth. This adjustment reflects confidence in the brand's potential to attract more customers and boost sales, especially with the renewed interest in fashion events. Investors are likely to view this as a positive sign for the company's future performance.
Jefferies reiterates Buy rating on Snowflake stock, maintains $270 price target
PositiveFinancial Markets
Jefferies has reaffirmed its Buy rating on Snowflake stock, maintaining a price target of $270. This endorsement is significant as it reflects confidence in Snowflake's growth potential and market position, which could attract more investors and positively influence the stock's performance.
McDonald’s stock rating reiterated at Buy by Jefferies on value meals
PositiveFinancial Markets
Jefferies has reaffirmed its Buy rating on McDonald's stock, highlighting the company's value meals as a key driver for growth. This endorsement reflects confidence in McDonald's ability to attract budget-conscious consumers, especially in today's economic climate. As more people seek affordable dining options, McDonald's value offerings could enhance its market position and profitability, making it an appealing investment choice.
Jefferies downgrades Edison International on wildfire liabilities
NegativeFinancial Markets
Jefferies has downgraded Edison International due to concerns over potential wildfire liabilities. This decision reflects the growing risks associated with climate change and the financial implications for utility companies. As wildfires become more frequent and severe, investors are increasingly wary of the costs that utilities may face, making this downgrade significant for stakeholders and the market.
Jefferies lowers Corteva stock price target to $85 from $92, maintains Buy rating
NeutralFinancial Markets
Jefferies has adjusted its price target for Corteva's stock from $92 to $85 while maintaining a Buy rating. This change reflects the firm's analysis of market conditions and Corteva's performance, indicating that despite the lowered target, they still see potential for growth in the company's stock. Investors should keep an eye on Corteva as it navigates these changes, as it could present opportunities in the agricultural sector.
EQT stock price target lowered to $68 from $70 at Jefferies
NegativeFinancial Markets
EQT's stock price target has been lowered from $70 to $68 by Jefferies, indicating a cautious outlook for the company. This adjustment reflects concerns about market conditions and the company's performance, which could impact investor confidence and trading activity. Such changes in stock price targets are significant as they can influence investment decisions and market trends.
Jefferies reiterates Buy rating on Corteva stock amid business split
PositiveFinancial Markets
Jefferies has reaffirmed its Buy rating on Corteva's stock, highlighting confidence in the company's future performance, especially in light of its upcoming business split. This decision reflects a positive outlook on Corteva's strategic direction and potential for growth, making it an attractive option for investors. The split is expected to unlock value and enhance operational focus, which could lead to increased shareholder returns.
Jefferies upgrades Sunrun on strong cash flow
PositiveFinancial Markets
Jefferies has upgraded its rating on Sunrun, citing strong cash flow as a key factor in this decision. This upgrade is significant as it reflects confidence in Sunrun's financial health and growth potential in the renewable energy sector. Investors may see this as a positive signal for the company's future performance, especially as the demand for solar energy continues to rise.
Jefferies upgrades Enanta Pharmaceuticals stock to Buy on RSV treatment potential
PositiveFinancial Markets
Jefferies has upgraded Enanta Pharmaceuticals' stock to a 'Buy' rating, highlighting the company's promising potential in developing treatments for respiratory syncytial virus (RSV). This upgrade is significant as it reflects growing confidence in Enanta's innovative approaches to tackling RSV, a virus that poses serious health risks, especially to infants and the elderly. Investors are likely to view this positively, as advancements in RSV treatments could lead to substantial market opportunities and improved health outcomes.
Latest from Financial Markets
Gold hits record high as investors eye supportive backdrop into 2026
PositiveFinancial Markets
Gold prices have reached a record high, driven by investor optimism and a supportive economic backdrop expected to last into 2026. This surge reflects growing confidence in gold as a safe-haven asset amidst global uncertainties, making it a crucial time for investors to consider their portfolios.
Frontdoor stock hits all-time high at 68.87 USD
PositiveFinancial Markets
Frontdoor's stock has reached an all-time high of 68.87 USD, marking a significant milestone for the company. This surge reflects strong investor confidence and could indicate positive growth prospects for Frontdoor in the future. Such performance not only boosts the company's market position but also enhances its appeal to potential investors.
True cost of becoming a mum highlighted in new data on pay
NegativeFinancial Markets
Recent data has shed light on the financial impact of motherhood in England, revealing that mothers experience a significant drop in earnings after having their first, second, and third child. This decline in pay highlights the challenges that many families face and raises important questions about the support systems in place for working mothers. Understanding these trends is crucial for policymakers and society as a whole, as it emphasizes the need for better maternity pay and workplace flexibility.
Top 5 Best Trading Platforms for Stocks in 2025
PositiveFinancial Markets
The article highlights the top five trading platforms for stocks in 2025, showcasing their features and benefits for investors. This is significant as it helps traders make informed decisions in a rapidly evolving market, especially with the rise of cryptocurrencies and changing financial landscapes.
Spire Inc stock hits 52-week high, reaching 82.14 USD
PositiveFinancial Markets
Spire Inc's stock has reached a new 52-week high, hitting 82.14 USD, which reflects strong investor confidence and positive market trends. This milestone is significant as it indicates the company's robust performance and potential for future growth, making it an exciting time for shareholders and market watchers alike.
How to stay safe during a storm and what to do in a power cut
NeutralFinancial Markets
As storms bring heavy rain and strong winds, it's crucial to know how to stay safe and what to do during a power cut. Understanding these safety measures can help protect your home and ensure your well-being during severe weather events.